The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 240K | $0.04 | $10K |
| Jun 24, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 115K | $0.05 | $5K |
| Jun 23, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 75K | $0.05 | $3K |
| Jun 22, 2026 | Shah Amit B. | CFO | Buy(P) | 20K | $0.05 | $1K |
| Jun 22, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 65K | $0.05 | $3K |
| Jun 17, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 240K | $0.04 | $11K |
| Jun 15, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 96K | $0.05 | $4K |
| Jan 22, 2026 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Nov 17, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Jul 10, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 104K | $0.01 | $1K |
| Jul 9, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 1 | $0.01 | $0 |
| Jul 8, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 95K | $0.01 | $947 |
| Jan 31, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 64K | $0.03 | $2K |
| Jan 30, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 100K | $0.03 | $3K |
| Jan 29, 2025 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 183K | $0.03 | $5K |
| Nov 22, 2024 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 298K | $0.03 | $9K |
| Aug 23, 2024 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 500K | $0.02 | $10K |
| Jun 29, 2023 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 425K | $0.02 | $9K |
| Jun 28, 2023 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 75K | $0.03 | $2K |
| Jun 16, 2023 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 100K | $0.03 | $3K |
| Jun 14, 2023 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 400K | $0.03 | $12K |
| May 26, 2023 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 127K | $0.03 | $4K |
| May 2, 2023 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 100K | $0.05 | $5K |
| Dec 6, 2022 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 120K | $0.05 | $6K |
| Nov 22, 2022 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 70K | $0.08 | $6K |
| Sep 26, 2022 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 20K | $0.07 | $1K |
| Aug 25, 2022 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Buy(P) | 80K | $0.08 | $6K |
| Sep 3, 2021 | Saund Saran | Chief Business Officer | Grant(A) | 675K | — | $0 |
| Sep 3, 2021 | King Steven W | Director | Grant(A) | 500K | — | $0 |
| Sep 3, 2021 | Maida Anthony E III | Chief Clin. Ops. Officer, Director | Grant(A) | 600K | — | $0 |
| Sep 3, 2021 | Trieu Vuong | Chief Executive Officer, Director | Grant(A) | 225K | — | $0 |
| Jul 8, 2021 | Saund Saran | CHIEF BUSINESS OFFICER | Grant(A) | 103K | — | $0 |
| Jul 8, 2021 | Saund Saran | CHIEF BUSINESS OFFICER | Grant(A) | 216K | — | $0 |
| Jul 8, 2021 | Diamond David | Director | Grant(A) | 451K | — | $0 |
| Jul 8, 2021 | Shah Amit B. | CHIEF FINANCIAL OFFICER | Grant(A) | 299K | — | $0 |
| Jul 8, 2021 | Shah Amit B. | CHIEF FINANCIAL OFFICER | Grant(A) | 698K | — | $0 |
| Jul 8, 2021 | King Steven W | Director | Grant(A) | 357K | — | $0 |
| Jul 8, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Grant(A) | 259K | — | $0 |
| Jul 8, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Grant(A) | 514K | — | $0 |
| Jul 8, 2021 | Maida Anthony E III | CHIEF CLINICAL OFFICER, Director | Grant(A) | 400K | — | $0 |
| Mar 31, 2021 | Saund Saran | CHIEF BUSINESS OFFICER | Conversion(C) | 16.4M | — | — |
| Mar 31, 2021 | Saund Saran | CHIEF BUSINESS OFFICER | Conversion(C) | 16K | — | — |
| Mar 31, 2021 | King Steven W | Director | Conversion(C) | 3.3M | — | — |
| Mar 31, 2021 | King Steven W | Director | Conversion(C) | 3K | — | — |
| Mar 31, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Conversion(C) | 74.5M | — | — |
| Mar 31, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Conversion(C) | 13.8M | — | — |
| Mar 31, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Conversion(C) | 5.7M | — | — |
| Mar 31, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Conversion(C) | 6K | — | — |
| Mar 31, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Conversion(C) | 14K | — | — |
| Mar 31, 2021 | Trieu Vuong | CHAIRMAN AND CEO, Director, 10% Owner | Conversion(C) | 74K | — | — |
| Mar 31, 2021 | Maida Anthony E III | CHIEF CLINICAL OFFICER, Director | Conversion(C) | 939K | — | — |
| Mar 31, 2021 | Maida Anthony E III | CHIEF CLINICAL OFFICER, Director | Conversion(C) | 938 | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).